“Udonitrectag” receives orphan drug designation from the European Commission as treatment in solid organ transplantation
On 15/11/2021, orphan designation (EU/3/21/2521) was granted by the European Commission to MIMETECH S.r.l., Italy, for Udonitrectag as treatment in solid organ transplantation. When organs are transplanted, the period in which they are cut off from their normal blood supply can lead to damage and death of cells that means …
